{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T12:55:15Z","timestamp":1793278515442,"version":"4.5.0"},"reference-count":169,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004328","name":"Genentech","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004328","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007824","name":"American Chemistry Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007824","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011912","name":"Washington University School of Medicine in St. Louis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011912","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013995","name":"Sanofi Genzyme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013995","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019120","name":"Otsuka America","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019120","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019851","name":"Aldeyra Therapeutics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019851","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004324","name":"Astellas Pharma US","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004324","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.jaip.2020.02.023","type":"journal-article","created":{"date-parts":[[2020,3,3]],"date-time":"2020-03-03T19:49:15Z","timestamp":1583264955000},"page":"1532-1549.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Clinical Research Needs for the Management of Chronic Rhinosinusitis with Nasal Polyps in the New Era of Biologics: A National Institute of Allergy and Infectious Diseases Workshop"],"prefix":"10.1016","volume":"8","author":[{"given":"Robert","family":"Naclerio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuad","family":"Baroody","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus","family":"Bachert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Bleier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry","family":"Borish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Brittain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey","family":"Chupp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anat","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wytske","family":"Fokkens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Gevaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya M.","family":"Laidlaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jake J.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay F.","family":"Piccirillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayant M.","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren T.","family":"Roland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert P.","family":"Schleimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodney J.","family":"Schlosser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie M.","family":"Schwaninger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy L.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce K.","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elina","family":"Toskala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally","family":"Wenzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alkis","family":"Togias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2020.02.023_bib1","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1111\/j.1398-9995.2011.02646.x","article-title":"Chronic rhinosinusitis in Europe--an underestimated disease. A GA(2)LEN study","volume":"66","author":"Hastan","year":"2011","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2020.02.023_bib2","first-page":"1","article-title":"Summary health statistics for U.S. adults: national health interview survey, 2012","volume":"10","author":"Blackwell","year":"2014","journal-title":"Vital Health Stat"},{"key":"10.1016\/j.jaip.2020.02.023_bib3","doi-asserted-by":"crossref","first-page":"329","DOI":"10.4193\/Rhino15.157","article-title":"Prevalence and risk factors of chronic rhinosinusitis in South Korea according to diagnostic criteria","volume":"54","author":"Kim","year":"2016","journal-title":"Rhinology"},{"key":"10.1016\/j.jaip.2020.02.023_bib4","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/all.12577","article-title":"Epidemiology of chronic rhinosinusitis: results from a cross-sectional survey in seven Chinese cities","volume":"70","author":"Shi","year":"2015","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2020.02.023_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4193\/Rhino12.000","article-title":"EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists","volume":"50","author":"Fokkens","year":"2012","journal-title":"Rhinology"},{"key":"10.1016\/j.jaip.2020.02.023_bib6","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1001\/jamaoto.2015.3810","article-title":"Depression-specific outcomes after treatment of chronic rhinosinusitis","volume":"142","author":"Schlosser","year":"2016","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jaip.2020.02.023_bib7","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1002\/alr.22406","article-title":"Effects of endoscopic sinus surgery on objective and subjective measures of cognitive dysfunction in chronic rhinosinusitis","volume":"9","author":"Yoo","year":"2019","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jaip.2020.02.023_bib8","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1002\/lary.21847","article-title":"Health state utility values in patients undergoing endoscopic sinus surgery","volume":"121","author":"Soler","year":"2011","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jaip.2020.02.023_bib9","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1164\/rccm.201810-1944CI","article-title":"Role of biologics in asthma","volume":"199","author":"McGregor","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2020.02.023_bib10","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1016\/j.jaad.2017.12.022","article-title":"Dupilumab: a review of its use in the treatment of atopic dermatitis","volume":"78","author":"Gooderham","year":"2018","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jaip.2020.02.023_bib11","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/j.jaci.2015.10.010","article-title":"Current and future treatment options for adult chronic rhinosinusitis: focus on nasal polyposis","volume":"136","author":"Bachert","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.02.023_bib12","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.anai.2019.12.001","article-title":"Review article: biologics in chronic rhinosinusitis with nasal polyposis","volume":"124","author":"Laidlaw","year":"2020","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2020.02.023_bib13","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/j.jaci.2013.02.036","article-title":"Endotypes and phenotypes of chronic rhinosinusitis: a PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology","volume":"131","author":"Akdis","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.02.023_bib14","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jaci.2018.06.010","article-title":"NAVIGATE II: randomized, double-blind trial of the exhalation delivery system with fluticasone for nasal polyposis","volume":"143","author":"Leopold","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.02.023_bib15","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/alr.22084","article-title":"A\u00a0phase 3 trial of mometasone furoate sinus implants for chronic sinusitis with recurrent nasal polyps","volume":"8","author":"Kern","year":"2018","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jaip.2020.02.023_bib16","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/alr.22093","article-title":"Corticosteroid nasal irrigations are more effective than simple sprays in a randomized double-blinded placebo-controlled trial for chronic rhinosinusitis after sinus surgery","volume":"8","author":"Harvey","year":"2018","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jaip.2020.02.023_bib17","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/j.jaci.2009.09.018","article-title":"Pilot study of budesonide inhalant suspension irrigations for chronic eosinophilic sinusitis","volume":"124","author":"Steinke","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.02.023_bib18","doi-asserted-by":"crossref","first-page":"91","DOI":"10.21053\/ceo.2016.00220","article-title":"The effectiveness of budesonide nasal irrigation after endoscopic sinus surgery in chronic rhinosinusitis with asthma","volume":"10","author":"Kang","year":"2017","journal-title":"Clin Exp Otorhinolaryngol"},{"key":"10.1016\/j.jaip.2020.02.023_bib19","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/S0140-6736(19)31881-1","article-title":"Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials","volume":"394","author":"Bachert","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2020.02.023_bib20","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/lary.24916","article-title":"Economic evaluation of endoscopic sinus surgery versus continued medical therapy for refractory chronic rhinosinusitis","volume":"125","author":"Rudmik","year":"2015","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jaip.2020.02.023_bib21","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1002\/alr.21697","article-title":"Cost utility analysis of endoscopic sinus surgery for chronic rhinosinusitis","volume":"6","author":"Scangas","year":"2016","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jaip.2020.02.023_bib22","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/lary.26169","article-title":"Cost utility analysis of endoscopic sinus surgery for chronic rhinosinusitis with and without nasal polyposis","volume":"127","author":"Scangas","year":"2017","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jaip.2020.02.023_bib23","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/j.jaci.2015.08.037","article-title":"Direct costs of adult chronic rhinosinusitis by using 4 methods of estimation: results of the US Medical Expenditure Panel Survey","volume":"136","author":"Caulley","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.02.023_bib24","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s11882-017-0690-5","article-title":"Economics of chronic rhinosinusitis","volume":"17","author":"Rudmik","year":"2017","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.jaip.2020.02.023_bib25","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1177\/000348940911800305","article-title":"Assessing the additional disease burden of polyps in chronic rhinosinusitis","volume":"118","author":"Bhattacharyya","year":"2009","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.jaip.2020.02.023_bib26","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1002\/lary.27852","article-title":"Cost burden and resource utilization in patients with chronic rhinosinusitis and nasal polyps","volume":"129","author":"Bhattacharyya","year":"2019","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jaip.2020.02.023_bib27","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1177\/0194599810391852","article-title":"Cost burden of chronic rhinosinusitis: a claims-based study","volume":"144","author":"Bhattacharyya","year":"2011","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jaip.2020.02.023_bib28","first-page":"1","article-title":"Summary health statistics for U.S. adults: National Health Interview Survey, 1997","volume":"10","author":"Blackwell","year":"2002","journal-title":"Vital Health Stat"},{"key":"10.1016\/j.jaip.2020.02.023_bib29","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/00043764-200301000-00007","article-title":"The health and productivity cost burden of the \u201ctop 10\u201d physical and mental health conditions affecting six large U.S. employers in 1999","volume":"45","author":"Goetzel","year":"2003","journal-title":"J\u00a0Occup Environ Med"},{"key":"10.1016\/j.jaip.2020.02.023_bib30","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1177\/194589240301700106","article-title":"The economic burden and symptom manifestations of chronic rhinosinusitis","volume":"17","author":"Bhattacharyya","year":"2003","journal-title":"Am J Rhinol"},{"key":"10.1016\/j.jaip.2020.02.023_bib31","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1002\/lary.24630","article-title":"Productivity costs in patients with refractory chronic rhinosinusitis","volume":"124","author":"Rudmik","year":"2014","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jaip.2020.02.023_bib32","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1001\/jamaoto.2015.2321","article-title":"Effect of continued medical therapy on productivity costs for refractory chronic rhinosinusitis","volume":"141","author":"Rudmik","year":"2015","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jaip.2020.02.023_bib33","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1002\/lary.25656","article-title":"Productivity costs decrease after endoscopic sinus surgery for refractory chronic rhinosinusitis","volume":"126","author":"Rudmik","year":"2016","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jaip.2020.02.023_bib34","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1002\/alr.21588","article-title":"Health utility outcomes in patients undergoing medical management for chronic rhinosinusitis: a prospective multiinstitutional study","volume":"5","author":"Luk","year":"2015","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jaip.2020.02.023_bib35","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1002\/alr.22191","article-title":"Productivity changes following medical and surgical treatment of chronic rhinosinusitis by symptom domain","volume":"8","author":"Beswick","year":"2018","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jaip.2020.02.023_bib36","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/lary.26723","article-title":"What drives productivity loss in chronic rhinosinusitis? A SNOT-22 subdomain analysis","volume":"128","author":"Chowdhury","year":"2018","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jaip.2020.02.023_bib37","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1002\/alr.22369","article-title":"Long-term outcomes of endoscopic sinus surgery in the management of adult chronic rhinosinusitis","volume":"9","author":"Smith","year":"2019","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jaip.2020.02.023_bib38","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.jaci.2015.12.1324","article-title":"Inflammatory endotypes of chronic rhinosinusitis based on cluster analysis of biomarkers","volume":"137","author":"Tomassen","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.02.023_bib39","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jaci.2012.07.047","article-title":"Omalizumab is effective in allergic and nonallergic patients with nasal polyps and asthma","volume":"131","author":"Gevaert","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.02.023_bib40","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.jaci.2011.07.056","article-title":"Mepolizumab, a humanized anti-IL-5 mAb, as a treatment option for severe nasal polyposis","volume":"128","author":"Gevaert","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.02.023_bib41","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.jaci.2017.05.044","article-title":"Reduced need for surgery in severe nasal polyposis with mepolizumab: randomized trial","volume":"140","author":"Bachert","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.02.023_bib42","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.jaci.2006.05.031","article-title":"Nasal IL-5 levels determine the response to anti-IL-5 treatment in patients with nasal polyps","volume":"118","author":"Gevaert","year":"2006","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.02.023_bib43","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1001\/jama.2015.19330","article-title":"Effect of subcutaneous dupilumab on nasal polyp burden in patients with chronic sinusitis and nasal polyposis: a randomized clinical trial","volume":"315","author":"Bachert","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jaip.2020.02.023_bib44","doi-asserted-by":"crossref","first-page":"573","DOI":"10.7326\/0003-4819-154-9-201105030-00002","article-title":"Omalizumab in severe allergic asthma inadequately controlled with standard therapy: a randomized trial","volume":"154","author":"Hanania","year":"2011","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaip.2020.02.023_bib45","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1164\/rccm.201208-1414OC","article-title":"Exploring the effects of omalizumab in allergic asthma: an analysis of biomarkers in the EXTRA study","volume":"187","author":"Hanania","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2020.02.023_bib46","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1056\/NEJMoa0808991","article-title":"Mepolizumab and exacerbations of refractory eosinophilic asthma","volume":"360","author":"Haldar","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2020.02.023_bib47","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1056\/NEJMoa1403290","article-title":"Mepolizumab treatment in patients with severe eosinophilic asthma","volume":"371","author":"Ortega","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2020.02.023_bib48","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1056\/NEJMoa1403291","article-title":"Oral glucocorticoid-sparing effect of mepolizumab in eosinophilic asthma","volume":"371","author":"Bel","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2020.02.023_bib49","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/S0140-6736(16)31324-1","article-title":"Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting beta2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial","volume":"388","author":"Bleecker","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2020.02.023_bib50","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1016\/S0140-6736(16)31322-8","article-title":"Benralizumab, an anti-interleukin-5 receptor alpha monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial","volume":"388","author":"FitzGerald","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2020.02.023_bib51","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(16)30307-5","article-title":"Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting beta2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial","volume":"388","author":"Wenzel","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2020.02.023_bib52","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1056\/NEJMoa1804093","article-title":"Efficacy and safety of dupilumab in glucocorticoid-dependent severe asthma","volume":"378","author":"Rabe","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2020.02.023_bib53","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1056\/NEJMoa1804092","article-title":"Dupilumab efficacy and safety in moderate-to-severe uncontrolled asthma","volume":"378","author":"Castro","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2020.02.023_bib54","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1111\/all.13875","article-title":"EUFOREA consensus on biologics for CRSwNP with or without asthma","volume":"74","author":"Fokkens","year":"2019","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2020.02.023_bib55","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1002\/lary.20653","article-title":"Long-term outcomes from the English national comparative audit of surgery for nasal polyposis and chronic rhinosinusitis","volume":"119","author":"Hopkins","year":"2009","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jaip.2020.02.023_bib56","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/lary.26391","article-title":"Prevalence of polyp recurrence after endoscopic sinus surgery for chronic rhinosinusitis with nasal polyposis","volume":"127","author":"DeConde","year":"2017","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jaip.2020.02.023_bib57","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1398-9995.2005.00688.x","article-title":"Prevalence of nasal polyposis in France: a cross-sectional, case-control study","volume":"60","author":"Klossek","year":"2005","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2020.02.023_bib58","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/j.jaci.2013.02.002","article-title":"Incidence and associated premorbid diagnoses of patients with chronic rhinosinusitis","volume":"131","author":"Tan","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.02.023_bib59","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/lary.26741","article-title":"Revision rates and time to revision following endoscopic sinus surgery: a large database analysis","volume":"128","author":"Stein","year":"2018","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jaip.2020.02.023_bib60","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.jaip.2019.08.024","article-title":"Trends and disparities in asthma biologic use in the United States","volume":"8","author":"Inselman","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2020.02.023_bib61","doi-asserted-by":"crossref","first-page":"192","DOI":"10.2500\/ajra.2014.28.4033","article-title":"Differences in initial immunoprofiles between recurrent and nonrecurrent chronic rhinosinusitis with nasal polyps","volume":"28","author":"Van Zele","year":"2014","journal-title":"Am J Rhinol Allergy"},{"key":"10.1016\/j.jaip.2020.02.023_bib62","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/cea.12472","article-title":"Pathogenesis of nasal polyposis","volume":"45","author":"Hulse","year":"2015","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2020.02.023_bib63","first-page":"OA5336","article-title":"Phase 1 evaluation of the inhaled IL-4Ra antagonist, AZD1402\/PRS-060, a potent and selective blocker of IL-4Ra","volume":"54","author":"Bruns","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2020.02.023_bib64","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1056\/NEJMoa1411776","article-title":"Allergen-induced asthmatic responses modified by a GATA3-specific DNAzyme","volume":"372","author":"Krug","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2020.02.023_bib65","doi-asserted-by":"crossref","first-page":"10026","DOI":"10.1074\/jbc.RA117.000567","article-title":"Small molecule targeting of the STAT5\/6 Src homology 2 (SH2) domains to inhibit allergic airway disease","volume":"293","author":"Knight","year":"2018","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jaip.2020.02.023_bib66","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.jaad.2018.01.018","article-title":"Baricitinib in adult patients with moderate-to-severe atopic dermatitis: a phase 2 parallel, double-blinded, randomized placebo-controlled multiple-dose study","volume":"80","author":"Guttman-Yassky","year":"2019","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jaip.2020.02.023_bib67","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/s41586-018-0449-8","article-title":"Allergic inflammatory memory in human respiratory epithelial progenitor cells","volume":"560","author":"Ordovas-Montanes","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.jaip.2020.02.023_bib68","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1111\/all.13222","article-title":"Beyond epithelial-to-mesenchymal transition: common suppression of differentiation programs underlies epithelial barrier dysfunction in mild, moderate, and severe asthma","volume":"72","author":"Loffredo","year":"2017","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2020.02.023_bib69","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1016\/j.jaci.2017.04.010","article-title":"Etiology of epithelial barrier dysfunction in patients with type 2 inflammatory diseases","volume":"139","author":"Schleimer","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.02.023_bib70","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.jaci.2015.01.043","article-title":"Oncostatin M promotes mucosal epithelial barrier dysfunction, and its expression is increased in patients with eosinophilic mucosal disease","volume":"136","author":"Pothoven","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.02.023_bib71","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1016\/j.jaci.2016.10.039","article-title":"Neutrophils are a major source of the epithelial barrier disrupting cytokine oncostatin M in patients with mucosal airways disease","volume":"139","author":"Pothoven","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.02.023_bib72","doi-asserted-by":"crossref","first-page":"R132","DOI":"10.1186\/ar4312","article-title":"Safety, tolerability, pharmacokinetics and pharmacodynamics of an anti-oncostatin M monoclonal antibody in rheumatoid arthritis: results from phase II randomized, placebo-controlled trials","volume":"15","author":"Choy","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jaip.2020.02.023_bib73","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1164\/rccm.201207-1292OC","article-title":"Excessive fibrin deposition in nasal polyps caused by fibrinolytic impairment through reduction of tissue plasminogen activator expression","volume":"187","author":"Takabayashi","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2020.02.023_bib74","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.alit.2017.03.007","article-title":"Nattokinase, profibrinolytic enzyme, effectively shrinks the nasal polyp tissue and decreases viscosity of mucus","volume":"66","author":"Takabayashi","year":"2017","journal-title":"Allergol Int"},{"key":"10.1016\/j.jaip.2020.02.023_bib75","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.jaci.2013.01.043","article-title":"Chronic rhinosinusitis with nasal polyps is characterized by B-cell inflammation and EBV-induced protein 2 expression","volume":"131","author":"Hulse","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.02.023_bib76","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/j.jaci.2011.08.037","article-title":"Evidence for intranasal antinuclear autoantibodies in patients with chronic rhinosinusitis with nasal polyps","volume":"128","author":"Tan","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.02.023_bib77","doi-asserted-by":"crossref","first-page":"AB237","DOI":"10.1016\/j.jaci.2014.12.1709","article-title":"Complement activation in nasal tissue of patients with chronic rhinosinusitis","volume":"135","author":"Van Roey","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.02.023_bib78","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1159\/000234295","article-title":"Comparison of arachidonic acid metabolism in nasal polyps and eosinophils","volume":"82","author":"Smith","year":"1987","journal-title":"Int Arch Allergy Appl Immunol"},{"key":"10.1016\/j.jaip.2020.02.023_bib79","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1164\/ajrccm\/147.4.1024","article-title":"Histochemical evidence for induction of arachidonate 15-lipoxygenase in airway disease","volume":"147","author":"Shannon","year":"1993","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.jaip.2020.02.023_bib80","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/s41588-018-0314-6","article-title":"A\u00a0loss-of-function variant in ALOX15 protects against nasal polyps and chronic rhinosinusitis","volume":"51","author":"Kristjansson","year":"2019","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaip.2020.02.023_bib81","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1046\/j.1365-2222.2002.01477.x","article-title":"Expression and activation of 15-lipoxygenase pathway in severe asthma: relationship to eosinophilic phenotype and collagen deposition","volume":"32","author":"Chu","year":"2002","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2020.02.023_bib82","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/alr.22243","article-title":"Inhibition of arachidonate 15-lipoxygenase reduces the epithelial-mesenchymal transition in eosinophilic chronic rhinosinusitis with nasal polyps","volume":"9","author":"Yan","year":"2019","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jaip.2020.02.023_bib83","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1183\/20734735.015414","article-title":"Real-world research and its importance in respiratory medicine","volume":"11","author":"Price","year":"2015","journal-title":"Breathe (Sheff)"},{"key":"10.1016\/j.jaip.2020.02.023_bib84","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.jaci.2010.10.058","article-title":"How representative are clinical study patients with allergic rhinitis in primary care?","volume":"127","author":"Costa","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.02.023_bib85","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1161\/HYPERTENSIONAHA.111.171074","article-title":"Participation in a clinical trial enhances adherence and persistence to treatment: a retrospective cohort study","volume":"58","author":"van Onzenoort","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.jaip.2020.02.023_bib86","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s40463-017-0216-0","article-title":"Development and validation of an administrative data algorithm to identify adults who have endoscopic sinus surgery for chronic rhinosinusitis","volume":"46","author":"Macdonald","year":"2017","journal-title":"J\u00a0Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jaip.2020.02.023_bib87","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1002\/alr.21801","article-title":"A\u00a0validated case definition for chronic rhinosinusitis in administrative data: a Canadian perspective","volume":"6","author":"Rudmik","year":"2016","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jaip.2020.02.023_bib88","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1136\/thoraxjnl-2013-203897","article-title":"Design of the Subpopulations and Intermediate Outcomes in COPD Study (SPIROMICS)","volume":"69","author":"Couper","year":"2014","journal-title":"Thorax"},{"key":"10.1016\/j.jaip.2020.02.023_bib89","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1513\/AnnalsATS.201511-781OC","article-title":"The Cystic Fibrosis Foundation Patient Registry. Design and methods of a national observational disease registry","volume":"13","author":"Knapp","year":"2016","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.jaip.2020.02.023_bib91","series-title":"Handbook of Methods and Applications of Statistics in Clinical Trials, Volume 2: Planning, Analysis, and Inferential Methods","first-page":"102","article-title":"Conditional power in clinical trial monitoring","author":"Tan","year":"2014"},{"key":"10.1016\/j.jaip.2020.02.023_bib92","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1002\/sim.1688","article-title":"Increasing the sample size when the unblinded interim result is promising","volume":"23","author":"Chen","year":"2004","journal-title":"Stat Med"},{"key":"10.1016\/j.jaip.2020.02.023_bib93","series-title":"Group sequential methods with applications to clinical trials","author":"Jennison","year":"1999"},{"key":"10.1016\/j.jaip.2020.02.023_bib94","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1016\/j.amepre.2007.01.022","article-title":"The multiphase optimization strategy (MOST) and the sequential multiple assignment randomized trial (SMART): new methods for more potent eHealth interventions","volume":"32","author":"Collins","year":"2007","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.jaip.2020.02.023_bib95","first-page":"33","article-title":"An overview of the design and conduct of the BATTLE trials","volume":"4","author":"Liu","year":"2015","journal-title":"Chin Clin Oncol"},{"key":"10.1016\/j.jaip.2020.02.023_bib96","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/sim.4780080407","article-title":"Surrogate endpoints in clinical trials: definition and operational criteria","volume":"8","author":"Prentice","year":"1989","journal-title":"Stat Med"},{"key":"10.1016\/j.jaip.2020.02.023_bib97","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/alr.21724","article-title":"Safety analysis of long-term budesonide nasal irrigations in patients with chronic rhinosinusitis post endoscopic sinus surgery","volume":"6","author":"Soudry","year":"2016","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jaip.2020.02.023_bib98","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/alr.22487","article-title":"Revision surgery rates in chronic rhinosinusitis with nasal polyps: meta-analysis of risk factors","volume":"10","author":"Loftus","year":"2020","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jaip.2020.02.023_bib99","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/cpt1977224485","article-title":"Clinical biostatistics: XLI, hard science, soft data, and the challenges of choosing clinical variables in research","volume":"22","author":"Feinstein","year":"1977","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jaip.2020.02.023_bib100","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1001\/archotol.1997.01900110039006","article-title":"Relationship between patient-based descriptions of sinusitis and paranasal sinus computed tomographic findings","volume":"123","author":"Bhattacharyya","year":"1997","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jaip.2020.02.023_bib101","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2500\/105065899781389704","article-title":"Severity staging in chronic sinusitis: are CT scan findings related to patient symptoms?","volume":"13","author":"Stewart","year":"1999","journal-title":"Am J Rhinol"},{"key":"10.1016\/j.jaip.2020.02.023_bib102","article-title":"Reliability and sensitivity in the self-assessment of well-being","volume":"17","author":"Clarke","year":"1964","journal-title":"Bull Brit Psychol Soc"},{"key":"10.1016\/j.jaip.2020.02.023_bib103","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1365-2222.1988.tb02840.x","article-title":"Symptom scores as measures of the severity of rhinitis","volume":"18","author":"Linder","year":"1988","journal-title":"Clin Allergy"},{"key":"10.1016\/j.jaip.2020.02.023_bib104","series-title":"Clinimetrics","author":"Feinstein","year":"1987"},{"key":"10.1016\/j.jaip.2020.02.023_bib105","doi-asserted-by":"crossref","first-page":"371","DOI":"10.4065\/77.4.371","article-title":"Clinical Significance Consensus Meeting Group. Methods to explain the clinical significance of health status measures","volume":"77","author":"Guyatt","year":"2002","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jaip.2020.02.023_bib106","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/00031305.2016.1154108","article-title":"The ASA statement on p-values: context, process, and purpose","volume":"70","author":"Wasserstein","year":"2016","journal-title":"Am Stat"},{"key":"10.1016\/j.jaip.2020.02.023_bib107","first-page":"5","article-title":"A\u00a0technique for the measurement of attitudes","volume":"55","author":"Likert","year":"1932","journal-title":"Arch Psychol"},{"key":"10.1016\/j.jaip.2020.02.023_bib108","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1007\/s11136-018-1842-3","article-title":"PROMIS((R))-29 v2.0 profile physical and mental health summary scores","volume":"27","author":"Hays","year":"2018","journal-title":"Qual Life Res"},{"key":"10.1016\/j.jaip.2020.02.023_bib109","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short-form health survey (SF-36), I: conceptual framework and item selection","volume":"30","author":"Ware","year":"1992","journal-title":"Med Care"},{"key":"10.1016\/j.jaip.2020.02.023_bib110","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/alr.21866","article-title":"Evaluating metrics of responsiveness using patient-reported outcome measures in chronic rhinosinusitis","volume":"7","author":"Lidder","year":"2017","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jaip.2020.02.023_bib111","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1067\/mhn.2002.121022","article-title":"Psychometric and clinimetric validity of the 20-Item Sino-Nasal Outcome Test (SNOT-20)","volume":"126","author":"Piccirillo","year":"2002","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jaip.2020.02.023_bib112","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/j.1749-4486.2009.01995.x","article-title":"Psychometric validity of the 22-item Sinonasal Outcome Test","volume":"34","author":"Hopkins","year":"2009","journal-title":"Clin Otolaryngol"},{"key":"10.1016\/j.jaip.2020.02.023_bib113","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1016\/j.jaci.2015.10.012","article-title":"Patient-reported outcome measures for adult chronic rhinosinusitis: a systematic review and quality assessment","volume":"136","author":"Rudmik","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.02.023_bib114","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1177\/0194599818773065","article-title":"Systematic review and meta-analysis of SNOT-22 outcomes after surgery for chronic rhinosinusitis with nasal polyposis","volume":"159","author":"Le","year":"2018","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jaip.2020.02.023_bib115","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1288\/00005537-199001000-00016","article-title":"Functional endoscopic sinus surgery: evaluation, surgery, and follow-up of 250 patients","volume":"100","author":"Levine","year":"1990","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jaip.2020.02.023_bib116","first-page":"183","article-title":"Mackay IS. Staging in rhinosinusitus","volume":"31","author":"Lund","year":"1993","journal-title":"Rhinology"},{"key":"10.1016\/j.jaip.2020.02.023_bib117","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/j.1365-2273.1993.tb00628.x","article-title":"The effect of budesonide (Rhinocort) in the treatment of small and medium-sized nasal polyps","volume":"18","author":"Vendelo Johansen","year":"1993","journal-title":"Clin Otolaryngol Allied Sci"},{"key":"10.1016\/j.jaip.2020.02.023_bib118","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1365-2273.1995.tb00007.x","article-title":"Efficacy of topical corticosteroid powder for nasal polyps: a double-blind, placebo-controlled study of budesonide","volume":"20","author":"Lildholdt","year":"1995","journal-title":"Clin Otolaryngol Allied Sci"},{"key":"10.1016\/j.jaip.2020.02.023_bib119","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1177\/000348949510410s02","article-title":"Quantification for staging sinusitis. The Staging and Therapy Group","volume":"167","author":"Lund","year":"1995","journal-title":"Ann Otol Rhinol Laryngol Suppl"},{"key":"10.1016\/j.jaip.2020.02.023_bib120","doi-asserted-by":"crossref","first-page":"465","DOI":"10.3109\/00016489709113422","article-title":"Assessment and staging of nasal polyposis","volume":"117","author":"Malm","year":"1997","journal-title":"Acta Otolaryngol"},{"key":"10.1016\/j.jaip.2020.02.023_bib121","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1034\/j.1398-9995.1999.00095.x","article-title":"Nasal polyposis: eosinophils and interleukin-5","volume":"54","author":"Kramer","year":"1999","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2020.02.023_bib122","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1016\/j.jaci.2006.09.005","article-title":"Rhinosinusitis: developing guidance for clinical trials","volume":"118","author":"Meltzer","year":"2006","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.02.023_bib123","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11882-016-0617-6","article-title":"Olfaction in chronic rhinosinusitis","volume":"16","author":"Rombaux","year":"2016","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.jaip.2020.02.023_bib124","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1097\/MLG.0b013e318184e216","article-title":"Predictors of olfactory dysfunction in patients with chronic rhinosinusitis","volume":"118","author":"Litvack","year":"2008","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jaip.2020.02.023_bib125","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2500\/105065801779954229","article-title":"Sense of smell in long-standing nasal polyposis","volume":"15","author":"Vento","year":"2001","journal-title":"Am J Rhinol"},{"key":"10.1016\/j.jaip.2020.02.023_bib126","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1177\/0003489417701939","article-title":"Correlation of symptoms, clinical signs, and biomarkers of inflammation in postsurgical chronic rhinosinusitis","volume":"126","author":"Racette","year":"2017","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.jaip.2020.02.023_bib127","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1007\/s00405-019-05413-9","article-title":"Correlation of tissue eosinophil count and chemosensory functions in patients with chronic rhinosinusitis with nasal polyps after endoscopic sinus surgery","volume":"276","author":"Zhang","year":"2019","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.jaip.2020.02.023_bib128","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1016\/j.jaip.2019.05.009","article-title":"Associations between inflammatory endotypes and clinical presentations in chronic rhinosinusitis","volume":"7","author":"Stevens","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2020.02.023_bib129","doi-asserted-by":"crossref","first-page":"E304","DOI":"10.1002\/lary.27112","article-title":"Olfactory and middle meatal cytokine levels correlate with olfactory function in chronic rhinosinusitis","volume":"128","author":"Wu","year":"2018","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jaip.2020.02.023_bib130","doi-asserted-by":"crossref","first-page":"227","DOI":"10.4193\/Rhino14.196","article-title":"Post-operative budesonide irrigations for patients with polyposis: a blinded, randomized controlled trial","volume":"53","author":"Rawal","year":"2015","journal-title":"Rhinology"},{"key":"10.1016\/j.jaip.2020.02.023_bib131","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/coa.12665","article-title":"Outcomes in endoscopic sinus surgery: olfaction, nose scale and quality of life in a prospective cohort study","volume":"41","author":"Andrews","year":"2016","journal-title":"Clin Otolaryngol"},{"key":"10.1016\/j.jaip.2020.02.023_bib132","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s13223-014-0064-7","article-title":"A\u00a0retrospective study of the clinical benefit from acetylsalicylic acid desensitization in patients with nasal polyposis and asthma","volume":"10","author":"Ibrahim","year":"2014","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.jaip.2020.02.023_bib133","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/alr.21964","article-title":"Defining the minimal clinically important difference for olfactory outcomes in the surgical treatment of chronic rhinosinusitis","volume":"7","author":"Levy","year":"2017","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jaip.2020.02.023_bib134","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/chemse\/22.1.39","article-title":"\u2018Sniffin\u2019 sticks\u2019: olfactory performance assessed by the combined testing of odor identification, odor discrimination and olfactory threshold","volume":"22","author":"Hummel","year":"1997","journal-title":"Chem Senses"},{"key":"10.1016\/j.jaip.2020.02.023_bib135","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/s00405-018-5248-1","article-title":"Updated Sniffin\u2019 Sticks normative data based on an extended sample of 9139 subjects","volume":"276","author":"Oleszkiewicz","year":"2019","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.jaip.2020.02.023_bib136","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1097\/01.mlg.0000234915.51189.cb","article-title":"Clinical significance of results from olfactory testing","volume":"116","author":"Gudziol","year":"2006","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jaip.2020.02.023_bib137","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1177\/00034894041130S506","article-title":"Imaging for staging of rhinosinusitis","volume":"193","author":"Zinreich","year":"2004","journal-title":"Ann Otol Rhinol Laryngol Suppl"},{"key":"10.1016\/j.jaip.2020.02.023_bib138","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1177\/0194599813513881","article-title":"Computed tomography scans as an objective measure of disease severity in chronic rhinosinusitis","volume":"150","author":"Likness","year":"2014","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jaip.2020.02.023_bib139","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1177\/194589240501900116","article-title":"Correlation between preoperative symptom scores, quality-of-life questionnaires, and staging with computed tomography in patients with chronic rhinosinusitis","volume":"19","author":"Wabnitz","year":"2005","journal-title":"Am J Rhinol"},{"key":"10.1016\/j.jaip.2020.02.023_bib140","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jaci.2016.07.020","article-title":"Proton pump inhibitors decrease eotaxin-3\/CCL26 expression in patients with chronic rhinosinusitis with nasal polyps: possible role of the nongastric H,K-ATPase","volume":"139","author":"Min","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.02.023_bib141","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1002\/alr.21499","article-title":"Computer-assisted staging of chronic rhinosinusitis correlates with symptoms","volume":"5","author":"Garneau","year":"2015","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jaip.2020.02.023_bib142","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jaci.2006.03.012","article-title":"Short course of systemic corticosteroids in sinonasal polyposis: a double-blind, randomized, placebo-controlled trial with evaluation of outcome measures","volume":"118","author":"Hissaria","year":"2006","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.02.023_bib143","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/all.12778","article-title":"Measurements of nasal airflow and patency: a critical review with emphasis on the use of peak nasal inspiratory flow in daily practice","volume":"71","author":"Ottaviano","year":"2016","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2020.02.023_bib144","doi-asserted-by":"crossref","first-page":"426","DOI":"10.4193\/Rhino10.049","article-title":"Nasal obstruction and smell impairment in nasal polyp disease: correlation between objective and subjective parameters","volume":"48","author":"Hox","year":"2010","journal-title":"Rhinology"},{"key":"10.1016\/j.jaip.2020.02.023_bib145","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1111\/coa.12859","article-title":"Peak nasal inspiratory flow correlates with quality of life in functional endoscopic sinus surgery","volume":"42","author":"Whitcroft","year":"2017","journal-title":"Clin Otolaryngol"},{"key":"10.1016\/j.jaip.2020.02.023_bib146","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.jaci.2016.06.063","article-title":"Heterogeneous inflammatory patterns in chronic rhinosinusitis without nasal polyps in Chicago, Illinois","volume":"139","author":"Tan","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.02.023_bib147","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1002\/alr.22005","article-title":"A\u00a0prospective analysis evaluating tissue biopsy location and its clinical relevance in chronic rhinosinusitis with nasal polyps","volume":"7","author":"Weibman","year":"2017","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jaip.2020.02.023_bib148","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1111\/all.12644","article-title":"Novel scoring system and algorithm for classifying chronic rhinosinusitis: the JESREC study","volume":"70","author":"Tokunaga","year":"2015","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2020.02.023_bib149","doi-asserted-by":"crossref","first-page":"E61","DOI":"10.1002\/lary.27564","article-title":"Dexpramipexole depletes blood and tissue eosinophils in nasal polyps with no change in polyp size","volume":"129","author":"Laidlaw","year":"2019","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jaip.2020.02.023_bib150","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1164\/rccm.200905-0740OC","article-title":"Vascular endothelial growth factor drives autocrine epithelial cell proliferation and survival in chronic rhinosinusitis with nasal polyposis","volume":"180","author":"Lee","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jaip.2020.02.023_bib151","doi-asserted-by":"crossref","first-page":"E72","DOI":"10.1002\/lary.24305","article-title":"Cytokine correlation between sinus tissue and nasal secretions among chronic rhinosinusitis and controls","volume":"123","author":"Oyer","year":"2013","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jaip.2020.02.023_bib152","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1016\/j.jaci.2018.02.002","article-title":"Identification of clinically relevant chronic rhinosinusitis endotypes using cluster analysis of mucus cytokines","volume":"141","author":"Turner","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.02.023_bib153","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.jaci.2017.01.022","article-title":"Microparticles in nasal lavage fluids in chronic rhinosinusitis: potential biomarkers for diagnosis of aspirin-exacerbated respiratory disease","volume":"140","author":"Takahashi","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.02.023_bib154","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00634-2017","article-title":"Severe eosinophilic asthma: a roadmap to consensus","volume":"49","author":"Buhl","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2020.02.023_bib155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaci.2019.05.031","article-title":"Phenotypes and endotypes of adult asthma: moving toward precision medicine","volume":"144","author":"Kaur","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.02.023_bib156","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1002\/lary.25180","article-title":"Cost of adult chronic rhinosinusitis: a systematic review","volume":"125","author":"Smith","year":"2015","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jaip.2020.02.023_bib157","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/j.jaci.2013.07.009","article-title":"National burden of antibiotic use for adult rhinosinusitis","volume":"132","author":"Smith","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.02.023_bib158","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.jaip.2016.09.015","article-title":"Acute exacerbations mediate quality of life impairment in chronic rhinosinusitis","volume":"5","author":"Phillips","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2020.02.023_bib159","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/cea.12463","article-title":"Immunological profiling in chronic rhinosinusitis with nasal polyps reveals distinct VEGF and GM-CSF signatures during symptomatic exacerbations","volume":"45","author":"Divekar","year":"2015","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2020.02.023_bib160","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/alr.22332","article-title":"Clinical predictors of cystic fibrosis chronic rhinosinusitis severity","volume":"9","author":"Zemke","year":"2019","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jaip.2020.02.023_bib161","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/lio2.208","article-title":"Chronic rhinosinusitis control from the patient and physician perspectives","volume":"3","author":"Sedaghat","year":"2018","journal-title":"Laryngoscope Investig Otolaryngol"},{"key":"10.1016\/j.jaip.2020.02.023_bib162","doi-asserted-by":"crossref","first-page":"98","DOI":"10.2500\/ajra.2013.27.3850","article-title":"A\u00a0proposed model to study immunologic changes during chronic rhinosinusitis exacerbations: data from a pilot study","volume":"27","author":"Rank","year":"2013","journal-title":"Am J Rhinol Allergy"},{"key":"10.1016\/j.jaip.2020.02.023_bib163","doi-asserted-by":"crossref","first-page":"9479","DOI":"10.1038\/s41598-017-08375-2","article-title":"The role of periostin in the occurrence and progression of eosinophilic chronic sinusitis with nasal polyps","volume":"7","author":"Xu","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jaip.2020.02.023_bib164","doi-asserted-by":"crossref","first-page":"11450","DOI":"10.1038\/s41598-018-29612-2","article-title":"Periostin as a novel biomarker for postoperative recurrence of chronic rhinosinitis with nasal polyps","volume":"8","author":"Ninomiya","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.jaip.2020.02.023_bib165","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1165\/rcmb.2017-0325OC","article-title":"Expression and functional analysis of CST1 in intractable nasal polyps","volume":"59","author":"Kato","year":"2018","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.jaip.2020.02.023_bib166","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.jaci.2019.03.026","article-title":"Epithelium-derived cystatin SN enhances eosinophil activation and infiltration through IL-5 in patients with chronic rhinosinusitis with nasal polyps","volume":"144","author":"Yan","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.02.023_bib167","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1002\/alr.22407","article-title":"Escalation in mucus cystatin 2, pappalysin-A, and periostin levels over time predict need for recurrent surgery in chronic rhinosinusitis with nasal polyps","volume":"9","author":"Mueller","year":"2019","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.jaip.2020.02.023_bib168","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1034\/j.1399-3003.1999.14d29.x","article-title":"Development and validation of a questionnaire to measure asthma control","volume":"14","author":"Juniper","year":"1999","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaip.2020.02.023_bib169","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.jaci.2012.10.022","article-title":"Reliability, validity, and responsiveness of the Rhinitis Control Assessment Test in patients with rhinitis","volume":"131","author":"Meltzer","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.02.023_bib170","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/alr.22264","article-title":"Long-term revision rates for endoscopic sinus surgery","volume":"9","author":"Smith","year":"2019","journal-title":"Int Forum Allergy Rhinol"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219820301835?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219820301835?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:24:26Z","timestamp":1761974666000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219820301835"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":169,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S2213219820301835"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2020.02.023","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Research Needs for the Management of Chronic Rhinosinusitis with Nasal Polyps in the New Era of Biologics: A National Institute of Allergy and Infectious Diseases Workshop","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2020.02.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}